Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Graupera

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Gastroenterology|September 17, 2020
Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and PrognosisCristina Solé, Susie Guilly, Kevin Da Silva, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2023
Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular ProfilingJordi Gratacós-Ginès, Emma Avitabile, Carla Montironi, et al.
Hepatology (Baltimore, Md.)|February 28, 2019
Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective StudyPatricia Huelin, Elsa Solà, Chiara Elia, et al.
The Lancet. Gastroenterology & Hepatology|June 2, 2026
Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort studyJesse Pustjens, Katrine Tholstrup Bech, Guillem Pera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2018
High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based StudyLlorenç Caballería, Guillem Pera, Ingrid Arteaga, et al.
Journal of Hepatology|August 31, 2019
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and AsiaMiquel Serra-Burriel, Isabel Graupera, Pere Torán, et al.
Plos One|September 19, 2018
Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based studyNúria Fabrellas, Rosario Hernández, Isabel Graupera, et al.
Gastroenterologia Y Hepatologia|March 6, 2022
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)Rocío Gallego-Durán, Agustín Albillos, Javier Ampuero, et al.
Journal of Hepatology|July 17, 2016
Plasma copeptin as biomarker of disease progression and prognosis in cirrhosisElsa Solà, Annarein J C Kerbert, Hein W Verspaget, et al.
Journal of Hepatology|August 24, 2018
Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trialElsa Solà, Cristina Solé, Macarena Simón-Talero, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Gastroenterology|September 17, 2020
Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and PrognosisCristina Solé, Susie Guilly, Kevin Da Silva, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2023
Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular ProfilingJordi Gratacós-Ginès, Emma Avitabile, Carla Montironi, et al.
Hepatology (Baltimore, Md.)|February 28, 2019
Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective StudyPatricia Huelin, Elsa Solà, Chiara Elia, et al.
The Lancet. Gastroenterology & Hepatology|June 2, 2026
Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort studyJesse Pustjens, Katrine Tholstrup Bech, Guillem Pera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2018
High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based StudyLlorenç Caballería, Guillem Pera, Ingrid Arteaga, et al.
Journal of Hepatology|August 31, 2019
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and AsiaMiquel Serra-Burriel, Isabel Graupera, Pere Torán, et al.
Plos One|September 19, 2018
Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based studyNúria Fabrellas, Rosario Hernández, Isabel Graupera, et al.
Gastroenterologia Y Hepatologia|March 6, 2022
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)Rocío Gallego-Durán, Agustín Albillos, Javier Ampuero, et al.
Journal of Hepatology|July 17, 2016
Plasma copeptin as biomarker of disease progression and prognosis in cirrhosisElsa Solà, Annarein J C Kerbert, Hein W Verspaget, et al.
Journal of Hepatology|August 24, 2018
Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trialElsa Solà, Cristina Solé, Macarena Simón-Talero, et al.
Pageof 11